Intervention with homoeopathy in the management of breast cancer patient in reference to quality of life

To Study The Effect Of Homoeopathic Treatment To Improve Quality Of Life In Patients Of Breast Cancer

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/047852

Enrollment

100

Registered

2022-12-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Constitutional Homoeopathic Medicine: Dosage:- will vary according to case from Mother tincture to CM and LM potency Frequency:- Depending on the case TDS or QID According to the patien

Eligibility

Inclusion criteria

Inclusion criteria: All types of Breast Cancer Patients ready to sign the consent form

Exclusion criteria

Exclusion criteria: 1. No male patients 2. No patients below the age of 18 years and above 75 years 3. Patients unwilling to sign the consent for

Design outcomes

Primary

Measure	Time frame
5 month to collect the sample size and and then the cases will be followed every 2 weeks with Quality of life analysis over the period of one yearTimepoint: the effect of the interventional group will be assessed every 15 days or 2 weeks with QAL Br 30 over the period of 1 year	—

Secondary

Measure	Time frame
made attempts at quantifying such changes towards improvement in quality of life in breast cancer patient Timepoint: the effects will be assessed on QAL Br 30 every 3month i.e 3rd month, 6 month , 9 month, and 12 month	—

Countries

India

Contacts

Public ContactDr Varada Vishal Phule

Bharati Vidhyapeeth Deemed to be University Homoeopathic Medical College and Hospital

drarunbjadhav@gmail.com7387191547

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026